• Profile
Close

Primary cervical screening with high risk human papillomavirus testing: Observational study

BMJ Feb 13, 2019

Rebolj M, et al. - In comparison with contemporary primary liquid based cytology screening, researchers offered the initial report on the chief results of the prevalence and incidence rounds of a large pilot of routine primary high-risk human papillomavirus (hrHPV) tests in England. Between May 2013 and December 2014, 578,547 women were subjected to cervical screening in primary care, followed-up until May 2017; 183,970 (32%) were screened with hrHPV testing. The results obtained from the observational study indicate that routine primary hrHPV screening in England increased the detection of cervical intraepithelial neoplasia grade 3 or worse and cervical cancer by nearly 40% and 30%, respectively, vs liquid-based cytology. After three years, the very low incidence of cervical intraepithelial neoplasia grade 3 or worse support an increase in the screening interval.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay